Bharat Biotech Inks Licensing Deal with Washington University School of Medicine in St. Louis to advance COVID-19 Intranasal Vaccine Technology

Vaccine Innovator, Bharat Biotech announces today, a licensing agreement with Washington University School of Medicine in St. Louis for a novel chimp- adenovirus, single dose intranasal vaccine for COVID-19. Bharat Biotech owns the rights to distribute the vaccine in all markets except USA, Japan and Europe.

source https://www.pharmatutor.org/pharma-news/2020/bharat-biotech-inks-licensing-deal-with-washington-university-school-of-medicine-in-st-louis-to-advance-covid-19-intranasal-vaccine-technology